Matly David bought INBX
April 24, 2026 · Form 4 insider transaction
Matly David bought 50,000 shares of Inhibrx Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderMatly David
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 24, 2026
Filing dateApril 27, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on April 24, 2027, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.